New diabetes clinical trial: Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus

Published on: June 02, 2023 at 11:00AM
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: LID104;   Drug: Dapagliflozin;   Drug: Linagliptin
Sponsor:   EMS
Not yet recruiting
https://ift.tt/IzuyQoN